Cargando…

Ethanol-Induced Atrial Fibrillation Results From Late I(Na) and Can Be Prevented by Ranolazine

Detalles Bibliográficos
Autores principales:	Mustroph, Julian, Baier, Maria J., Unsin, Denise, Provaznik, Zdenek, Kozakov, Kostiantyn, Lebek, Simon, Tarnowski, Daniel, Schildt, Sönke, Voigt, Niels, Wagner, Stefan, Maier, Lars S., Neef, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437457/ https://www.ncbi.nlm.nih.gov/pubmed/37603603 http://dx.doi.org/10.1161/CIRCULATIONAHA.123.064561

Ejemplares similares

Ranolazine for atrial fibrillation: buy one get three beneficial mechanisms!
por: Maier, Lars S.
Publicado: (2012)

A Pilot Trial to Compare the Long-Term Efficacy of Pulmonary Vein Isolation with High-Power Short-Duration Radiofrequency Versus Laser Energy with Rapid Ablation Mode
por: Schildt, Sönke, et al.
Publicado: (2023)

Refractory atrial fibrillation effectively treated with ranolazine
por: Vaishnav, Aditi, et al.
Publicado: (2014)

Angiotensin‐converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin‐converting enzyme 2 in patients with cardiovascular disease
por: Lebek, Simon, et al.
Publicado: (2020)

Empagliflozin Inhibits Cardiac Late Sodium Current by Ca/Calmodulin-Dependent Kinase II
por: Mustroph, Julian, et al.
Publicado: (2022)

Cardiac iron overload promotes cardiac injury in patients with severe COVID-19
por: Baier, Maria J., et al.
Publicado: (2021)

Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillation
por: Verrier, Richard L., et al.
Publicado: (2013)

The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation
por: Murdock, David K, et al.
Publicado: (2008)

Ranolazine in the prevention and treatment of atrial fibrillation: A protocol for meta-analysis
por: Yuan, Chengdai, et al.
Publicado: (2021)

Mechanism of action of the new anti-ischemia drug ranolazine
por: Hasenfuss, G., et al.
Publicado: (2007)

Proton-dependent inhibition of the cardiac sodium channel Na(v)1.5 by ranolazine
por: Sokolov, S., et al.
Publicado: (2013)

Pharmacologic modulation of intracellular Na(+) concentration with ranolazine impacts inflammatory response in humans and mice
por: Lenz, Max, et al.
Publicado: (2022)

Ranolazine for Prevention of Atrial Fibrillation after Cardiac Surgery: A Systematic Review
por: Patel, Nirav, et al.
Publicado: (2018)

Update on ranolazine in the management of angina
por: Codolosa, J Nicolás, et al.
Publicado: (2014)

Ranolazine for Angina in Hypertrophic Cardiomyopathy
por: Amin, Akhtar, et al.
Publicado: (2018)

Ranolazine: A Contemporary Review
por: Rayner‐Hartley, Erin, et al.
Publicado: (2016)

Ranolazine Toxicity Secondary to Paxlovid
por: Casey, Bradley, et al.
Publicado: (2023)

The Effect of Gender and Sex Hormones on Cardiovascular Disease, Heart Failure, Diabetes, and Atrial Fibrillation in Sleep Apnea
por: Hegner, Philipp, et al.
Publicado: (2021)

Antiarrhythmic Effect of Ranolazine in Combination with Selective NCX-Inhibition in an Experimental Model of Atrial Fibrillation
por: Wolfes, Julian, et al.
Publicado: (2020)

Antiarrhythmic Properties of Ranolazine: Inhibition of Atrial Fibrillation Associated TASK-1 Potassium Channels
por: Ratte, Antonius, et al.
Publicado: (2019)

Abnormal P‐wave terminal force in lead V(1) is a marker for atrial electrical dysfunction but not structural remodelling
por: Lebek, Simon, et al.
Publicado: (2021)

Ranolazine inhibits shear sensitivity of endogenous Na(+) current and spontaneous action potentials in HL-1 cells
por: Strege, Peter, et al.
Publicado: (2012)

Ranolazine inhibits Na(V)1.5-mediated breast cancer cell invasiveness and lung colonization
por: Driffort, Virginie, et al.
Publicado: (2014)

Antiarrhythmic Effects of Combining Dofetilide and Ranolazine in a Model of Acutely Induced Atrial Fibrillation in Horses
por: Carstensen, Helena, et al.
Publicado: (2018)

Empagliflozin inhibits Na(+)/H(+) exchanger activity in human atrial cardiomyocytes
por: Trum, Maximilian, et al.
Publicado: (2020)

A Rare Neurological Complication of Ranolazine
por: Porhomayon, Jahan, et al.
Publicado: (2013)

Renal phospholipidosis possibly induced by ranolazine
por: Scheurle, Christoph, et al.
Publicado: (2014)

Improvement of Vascular Insulin Sensitivity by Ranolazine
por: Guerra-Ojeda, Sol, et al.
Publicado: (2023)

Effects of ranolazine on wild-type and mutant hNa(v)1.7 channels and on DRG neuron excitability
por: Estacion, Mark, et al.
Publicado: (2010)

Antagonism of Na(v) channels and α(1)-adrenergic receptors contributes to vascular smooth muscle effects of ranolazine
por: Virsolvy, Anne, et al.
Publicado: (2015)

Atrial-ventricular differences in rabbit cardiac voltage-gated Na(+) currents: Basis for atrial-selective block by ranolazine
por: Caves, Rachel E., et al.
Publicado: (2017)

Efficacy of ranolazine in preventing atrial fibrillation following cardiac surgery: Results from a meta-analysis
por: Trivedi, Chintan, et al.
Publicado: (2017)

Effects of dofetilide and ranolazine on atrial fibrillatory rate in a horse model of acutely induced atrial fibrillation
por: Carstensen, Helena, et al.
Publicado: (2019)

Utility of ranolazine in chronic stable angina patients
por: Patel, Pawan D, et al.
Publicado: (2008)

Emerging clinical role of ranolazine in the management of angina
por: Vadnais, David S, et al.
Publicado: (2010)

Effects of Ranolazine on Astrocytes and Neurons in Primary Culture
por: Aldasoro, Martin, et al.
Publicado: (2016)

Keratolysis exfoliativa-like eruption induced by ranolazine
por: Pierobon, Elena, et al.
Publicado: (2022)

CaMKII regulation of cardiac K channels
por: Mustroph, Julian, et al.
Publicado: (2014)

SAR296968, a Novel Selective Na(+)/Ca(2+) Exchanger Inhibitor, Improves Ca(2+) Handling and Contractile Function in Human Atrial Cardiomyocytes
por: Hegner, Philipp, et al.
Publicado: (2022)

Phosphorylation of RyR2 Ser‐2814 by CaMKII mediates β1‐adrenergic stress induced Ca(2+)‐leak from the sarcoplasmic reticulum
por: Baier, Maria J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bgjr0k45m1g7jj1k0s1i8u926b